cannabis investing Captor Capital Reports Revenues of $2.1 Million in Unaudited Interim Financial Statements for the Three Months Ended December 31, 2019
cannabis investing Captor Capital Reports Higher Revenues and Lower Expenses in Unaudited Interim Financial Statements for the Three Months Ended September 30, 2019
cannabis investing Captor Capital Announces Filing of its Audited Annual Financial Statements for the Year Ended March 31, 2019 and its Unaudited Interim Financial Statements for the Three Months Ended June 30, 2019
cannabis investing Captor Capital Corp. Expands Presence in California with the Acquisition of Key Extracts Company
E-Power Resources Inc. Announces Flow-Through and Hard Dollar Private Placements to Fund Summer Work Program
Juggernaut Exploration: Advancing High-grade Precious Metals Assets in Northern BC’s Golden Triangle
New INNspired Article Spotlights Rare Earth Recycling as a Strategic Investment Opportunity in U.S. Critical Mineral Supply Chain
Radiopharm Theranostics Granted U.S. Food and Drug Administration Fast Track Designation for RAD101 Imaging in Brain Metastases
